BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 20362789)

  • 1. Adjuvant and neoadjuvant therapy in curable pancreatic cancer.
    Nugent FW; Stuart K
    Surg Clin North Am; 2010 Apr; 90(2):323-39. PubMed ID: 20362789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curative radiation therapy for pancreatic malignancies.
    Cooke EW; Hazard L
    Surg Clin North Am; 2010 Apr; 90(2):341-54. PubMed ID: 20362790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant treatment for pancreatic cancer.
    Daoud V; Saif MW; Goodman M
    JOP; 2014 Jul; 15(4):348-50. PubMed ID: 25076340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional chemotherapy in locally advanced pancreatic cancer: RECLAP trial.
    Davis JL; Pandalai P; Ripley RT; Langan RC; Steinberg SM; Walker M; Toomey MA; Levy E; Avital I
    Trials; 2011 May; 12():129. PubMed ID: 21595953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chemotherapy, chemoradiotherapy or observation after complete resection of pancreatic adenocarcinoma?].
    Lluís F
    Gastroenterol Hepatol; 2009 Feb; 32(2):120-1. PubMed ID: 19231687
    [No Abstract]   [Full Text] [Related]  

  • 6. [Radically resected pancreatic cancer and adjuvant treatment. A review of the literature].
    Drudi F; Tassinari D; Giuliani J; Ridolfi C; Gianni L; Tamburini E; Fantini M; Santelmo C; Barzotti E; Lotti N; Ravaioli A
    Recenti Prog Med; 2013 Feb; 104(2):80-5. PubMed ID: 23535964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chemoradiation for pancreatic adenocarcinoma].
    Flandin I; Mornex F; Claude L; Kubas A; Khodri M; Wautot V; Mazeron R; Partensky C
    Cancer Radiother; 2004 Nov; 8 Suppl 1():S80-7. PubMed ID: 15679252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant chemotherapy with gemcitabine for patients with resectable pancreatic cancer.
    Shivnani AT
    JAMA; 2007 Jun; 297(23):2581-2; author reply 2582. PubMed ID: 17579222
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of early-stage pancreatic cancer.
    Castellanos EH; Cardin DB; Berlin JD
    Oncology (Williston Park); 2011 Feb; 25(2):182-9. PubMed ID: 21456390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pancreatic carcinoma--overcome technically but not oncologically].
    Herfarth Ch
    Chirurg; 2003 Mar; 74(3):163-4. PubMed ID: 12722765
    [No Abstract]   [Full Text] [Related]  

  • 11. Neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer - the NEONAX trial (AIO-PAK-0313), a prospective, randomized, controlled, phase II study of the AIO pancreatic cancer group.
    Ettrich TJ; Berger AW; Perkhofer L; Daum S; König A; Dickhut A; Wittel U; Wille K; Geissler M; Algül H; Gallmeier E; Atzpodien J; Kornmann M; Muche R; Prasnikar N; Tannapfel A; Reinacher-Schick A; Uhl W; Seufferlein T
    BMC Cancer; 2018 Dec; 18(1):1298. PubMed ID: 30594153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant treatment strategies for pancreatic cancer.
    Newman EA; Simeone DM; Mulholland MW
    J Gastrointest Surg; 2006 Jun; 10(6):916-26. PubMed ID: 16769552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence-based guidelines for adjuvant therapy for resected adenocarcinoma of the pancreas.
    Iott MJ; Corsini MM; Miller RC
    Clin J Oncol Nurs; 2008 Aug; 12(4):599-605. PubMed ID: 18676327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Adjuvant treatment of pancreatic cancer].
    Oettle H
    Zentralbl Chir; 2003 May; 128(5):411-8. PubMed ID: 12813641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I study of twice-weekly gemcitabine and concomitant external-beam radiotherapy in patients with adenocarcinoma of the pancreas.
    Pipas JM; Mitchell SE; Barth RJ; Vera-Gimon R; Rathmann J; Meyer LP; Wagman RS; Lewis LD; McDonnell C; Colacchio TA; Perez RP
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1317-22. PubMed ID: 11483344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial.
    Oettle H; Post S; Neuhaus P; Gellert K; Langrehr J; Ridwelski K; Schramm H; Fahlke J; Zuelke C; Burkart C; Gutberlet K; Kettner E; Schmalenberg H; Weigang-Koehler K; Bechstein WO; Niedergethmann M; Schmidt-Wolf I; Roll L; Doerken B; Riess H
    JAMA; 2007 Jan; 297(3):267-77. PubMed ID: 17227978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative gemcitabine alone and concurrent with radiation therapy in locally advanced pancreatic carcinoma.
    Ozkok S; Demirci S; Yalman D; Zeytunlu M; Nart D; Yuzer Y; Coker A; Goker E
    Tumori; 2010; 96(4):560-7. PubMed ID: 20968135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Adjuvant chemotherapy for pancreatic cancer].
    Takeda S; Nakao A
    Nihon Rinsho; 2006 Jan; 64 Suppl 1():215-8. PubMed ID: 16457253
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term effects of multimodal treatment for patients with resectable carcinoma of the pancreas.
    Okabayashi T; Nishimori I; Nishioka A; Yamashita K; Sugimoto T; Dabanaka K; Maeda H; Kohsaki T; Ogawa Y; Kobayashi M; Onishi S; Hanazaki K
    Oncol Rep; 2008 Sep; 20(3):651-6. PubMed ID: 18695919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial.
    Oettle H; Neuhaus P; Hochhaus A; Hartmann JT; Gellert K; Ridwelski K; Niedergethmann M; Zülke C; Fahlke J; Arning MB; Sinn M; Hinke A; Riess H
    JAMA; 2013 Oct; 310(14):1473-81. PubMed ID: 24104372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.